ICF (NASDAQ:ICFI), a global consulting and digital services provider, was recently awarded a re-compete task order by 欧博娱乐 U.S. Centers for Disease Control and Prevention (CDC), Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) to support multiple aspects of its BioSense program, CDC’s cloud-based public health surveillance system.
The task order, which was awarded by 欧博娱乐 Division of Health Informatics and Surveillance (DHIS), has a value of $20 million and a term of one base year and two options years.
Part of 欧博娱乐 national emergency preparedness system, 欧博娱乐 BioSense syndromic surveillance system increases 欧博娱乐 ability of local, state and national health officials to monitor and respond to 欧博娱乐 harmful health effects of exposure to disease, addiction and hazardous conditions.
“Over 欧博娱乐 past few years, ICF has helped CDC significantly increase 欧博娱乐 national coverage of data providers and 欧博娱乐 number of jurisdictions and users that are supported by BioSense,” said Terence McKittrick, senior vice president for ICF. “The BioSense system stores nearly 40 terabytes of data, information crucial to 欧博娱乐 surveillance of important health issues such as 欧博娱乐 nation’s opioid crisis. We look forward to working with CDC to continue to improve this critical public health information system.”
ICF will provide expertise and support services to BioSense in 欧博娱乐 areas of surveillance, information management, technology and data management and analytics. Specifically, 欧博娱乐 company will help CDC expand of 欧博娱乐 scale and scope of 欧博娱乐 platform by continuing to help improve 欧博娱乐 quality of its surveillance data, enhance 欧博娱乐 technology of 欧博娱乐 BioSense platform and expand its coverage to build nationwide situational awareness capabilities with federal, state and local partners.
Read more about ICF’s public health services including health informatics, data management and disease surveillance.